PT2490684T - Métodos e formulações nutricionais para aumentar a eficácia e reduzir os efeitos secundários do tratamento oncológico - Google Patents

Métodos e formulações nutricionais para aumentar a eficácia e reduzir os efeitos secundários do tratamento oncológico

Info

Publication number
PT2490684T
PT2490684T PT108257718T PT10825771T PT2490684T PT 2490684 T PT2490684 T PT 2490684T PT 108257718 T PT108257718 T PT 108257718T PT 10825771 T PT10825771 T PT 10825771T PT 2490684 T PT2490684 T PT 2490684T
Authority
PT
Portugal
Prior art keywords
efficacy
methods
reduce
increase
side effects
Prior art date
Application number
PT108257718T
Other languages
English (en)
Inventor
D Longo Valter
Lee Changhan
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of PT2490684T publication Critical patent/PT2490684T/pt

Links

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L13/00Meat products; Meat meal; Preparation or treatment thereof
    • A23L13/60Comminuted or emulsified meat products, e.g. sausages; Reformed meat from comminuted meat product
    • A23L13/65Sausages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/20Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Business, Economics & Management (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Economics (AREA)
  • Quality & Reliability (AREA)
  • Strategic Management (AREA)
  • Tourism & Hospitality (AREA)
  • Physics & Mathematics (AREA)
  • General Business, Economics & Management (AREA)
  • Marketing (AREA)
  • Theoretical Computer Science (AREA)
  • Human Resources & Organizations (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Operations Research (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT108257718T 2009-10-22 2010-10-22 Métodos e formulações nutricionais para aumentar a eficácia e reduzir os efeitos secundários do tratamento oncológico PT2490684T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25415409P 2009-10-22 2009-10-22

Publications (1)

Publication Number Publication Date
PT2490684T true PT2490684T (pt) 2018-04-02

Family

ID=43900993

Family Applications (1)

Application Number Title Priority Date Filing Date
PT108257718T PT2490684T (pt) 2009-10-22 2010-10-22 Métodos e formulações nutricionais para aumentar a eficácia e reduzir os efeitos secundários do tratamento oncológico

Country Status (13)

Country Link
US (2) US20110118528A1 (pt)
EP (1) EP2490684B1 (pt)
JP (1) JP2013508411A (pt)
CN (1) CN102753162A (pt)
AU (2) AU2010310515B2 (pt)
BR (1) BR112012009423A2 (pt)
CA (1) CA2779282C (pt)
DK (1) DK2490684T3 (pt)
ES (1) ES2659353T3 (pt)
PL (1) PL2490684T3 (pt)
PT (1) PT2490684T (pt)
RU (1) RU2549954C2 (pt)
WO (1) WO2011050302A2 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2822178T3 (es) * 2012-10-22 2021-04-29 Univ Southern California Formulaciones dietéticas que promueven la regeneración de tejidos/órganos
US9237761B2 (en) * 2013-02-12 2016-01-19 University Of Southern California Methods and diets for lowering glucose and/or IGF-1 levels
US9386790B2 (en) * 2013-07-01 2016-07-12 University Of Southern California Fasting condition as dietary treatment of diabetes
US10172839B2 (en) 2014-03-06 2019-01-08 University Of Southern California Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues
ES2846153T3 (es) * 2014-03-06 2021-07-28 Univ Southern California Uso de régimen de inanición a corto plazo en combinación con inhibidores de cinasa para potenciar la eficacia y viabilidad de fármacos quimioterápicos tradicionales y revertir efectos secundarios de cinasas en células y tejidos normales
JP2017509671A (ja) * 2014-03-28 2017-04-06 ウニベルシタ デリィ ストゥディ ディ ジェノバ カロリー摂取量減少と協同したがん治療方法で使用されるチロシンキナーゼ阻害剤
EP3125904A4 (en) * 2014-04-02 2017-08-30 University of Southern California Autoimmunity and multiple sclerosis treatment
CA2982875C (en) 2015-04-16 2021-10-19 University Of Southern California Fasting mimicking diet (fmd) and glucose lowering drugs protect normal cells and generate cancer sensitizing conditions in response to standard and high glucose conditions induced by rapamycin and dexamethasone
CA2984891A1 (en) 2015-05-06 2016-11-10 University Of Southern California Fasting mimicking and enhancing diet for treating hypertension and lipid disorders
WO2017050849A1 (en) * 2015-09-21 2017-03-30 Ifom Fondazione Istituto Firc Di Oncologia Molecolare New therapeutic strategies against blood cancer
US20190029301A1 (en) * 2016-01-12 2019-01-31 University Of Southern California Use of long-term fasting mimicking as dietary treatment for multiple myeloma and other cancers
US10660932B2 (en) 2016-02-15 2020-05-26 University Of Southern California Drug combinations and methods to stimulate embryonic-like regeneration to treat diabetes and other diseases
EP4218751A3 (en) * 2016-02-23 2024-03-06 Cancer Research Technology Ltd Dietary product devoid of at least two non essential amino acid
ES2871060T3 (es) 2016-05-11 2021-10-28 Univ Southern California Dieta que imita el ayuno (FMD) como tratamiento inmunorregulador para enfermedades digestivas autoinmunitarias/inflamatorias
IT201700008499A1 (it) * 2017-01-26 2018-07-26 Univ Degli Studi Genova Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
CN107951892A (zh) * 2018-01-19 2018-04-24 丽水学院 锌原卟啉在制备增强人结直肠癌细胞对5-氟尿嘧啶化疗敏感性药物中的应用
AU2019236242A1 (en) 2018-03-15 2020-10-01 University Of Southern California Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology
DE212018000421U1 (de) * 2018-07-18 2021-03-01 Andreas Michalsen Auswirkungen einer kurzzeitigen Diät, die Fasten imitiert, auf die Lebensqualität und die Verträglichkeit einer Chemotherapie bei Patientinnen mit Krebs
CA3119100C (en) 2018-11-09 2024-06-04 Valter D. Longo Nutrition bar for intermittent fasting-mimicking
JP6747702B1 (ja) * 2019-05-10 2020-08-26 株式会社医療情報技術研究所 栄養処方管理システム
EP3968785A4 (en) 2019-05-14 2023-01-11 Tyme, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
JP7376718B2 (ja) * 2019-12-13 2023-11-08 株式会社ベリタスバイオセラピューティクス 癌の予防または治療用薬学組成物
IT202000007153A1 (it) 2020-04-03 2021-10-03 Ifom Fondazione St Firc Di Oncologia Molecolare Apporto calorico ridotto e immunoterapia per il trattamento del cancro
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections
CA3205396A1 (en) * 2020-12-17 2022-06-23 Licia Rivoltini Diet preparation for the nutrition of cancer patients with a restricted calorie intake
EP4066823A1 (en) 2021-03-30 2022-10-05 IFOM Fondazione Istituto Firc di Oncologia Molecolare Reduced caloric intake and anticancer agents for the treatment of cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2074731C1 (ru) * 1994-12-29 1997-03-10 Игорь Александрович Бойко Фитокомплекс, обладающий противоопухолевым действием, и способ лечения онкологических больных
JP4740426B2 (ja) * 1997-03-17 2011-08-03 ビーティージー・インターナショナル・リミテッド 治療用組成物
WO2001006983A2 (en) * 1999-07-22 2001-02-01 Incell Corporation, Llc Fatty acids to minimize cancer therapy side effects
WO2005117542A2 (en) * 2004-05-10 2005-12-15 Novacea, Inc. Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
WO2006043966A2 (en) * 2004-10-15 2006-04-27 University Of Tennessee Research Foundation Methods for inducing apoptosis in adipocytes
US20070116802A1 (en) * 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US20080038367A1 (en) * 2006-08-11 2008-02-14 Sal Saloum Nutritional supplement compositions and methods of preparing
RU2354369C2 (ru) * 2007-03-16 2009-05-10 Михаил Владимирович Кутушов Применение родамина 6ж в качестве лекарственного средства для лечения злокачественных новообразований и амилоидозов
US8211700B2 (en) * 2007-03-28 2012-07-03 University Of Southern California Induction of differential stress resistance and uses thereof
WO2009070378A1 (en) * 2007-11-26 2009-06-04 Nestec S.A. Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition

Also Published As

Publication number Publication date
BR112012009423A2 (pt) 2017-06-13
EP2490684A2 (en) 2012-08-29
US20110118528A1 (en) 2011-05-19
DK2490684T3 (en) 2018-04-09
WO2011050302A3 (en) 2011-08-25
CN102753162A (zh) 2012-10-24
AU2016201607B2 (en) 2017-11-30
WO2011050302A2 (en) 2011-04-28
AU2010310515B2 (en) 2016-01-07
CA2779282A1 (en) 2011-04-28
US20210209516A1 (en) 2021-07-08
EP2490684B1 (en) 2018-01-03
AU2010310515A1 (en) 2012-05-17
CA2779282C (en) 2017-12-05
PL2490684T3 (pl) 2018-07-31
AU2016201607A1 (en) 2016-03-31
RU2012118588A (ru) 2013-11-27
JP2013508411A (ja) 2013-03-07
RU2549954C2 (ru) 2015-05-10
ES2659353T3 (es) 2018-03-14
EP2490684A4 (en) 2016-05-04

Similar Documents

Publication Publication Date Title
PL2490684T3 (pl) Sposoby i formulacje odżywcze dla zwiększenia skuteczności i zmniejszenia skutków ubocznych leczenia nowotworu
ZA201207574B (en) Phytocannabinoids in the treatment of cancer
ZA201302979B (en) Dianosis and treatment relating to th2 inhibition
EP2645957A4 (en) ELIMINATION OF FAT BY NON-INVASIVE HYPERTHERMIC TREATMENT
PL3208612T3 (pl) Kompozycje i sposoby leczenia chorób o podłożu immunologicznym
IL225471A0 (en) Preparations and methods for the prevention and treatment of cancer
IL218575A0 (en) Treatment of cancer
EP2627333A4 (en) COMBINED TREATMENT OF CANCER
EP2558085A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CANCER
IL214349A0 (en) Compositions and methods for the treatment of cancer
EP2651894A4 (en) THIOSEMICARBAZONE COMPOUNDS FOR CANCER TREATMENT
EP2437738A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
IL214757A0 (en) Compositions and methods to prevent and/or treat cancer with pa-card
ZA201408057B (en) Compositions and methods for the treatment of moderate to severe pain
HRP20151393T8 (hr) UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE
EP2547368A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
EP2411031A4 (en) Methods and compositions for the treatment of cancer
GB201718726D0 (en) Phytocannabinoids in the treatment of cancer
HK1214771A1 (zh) 用於治療皮膚病的製劑
GB0916686D0 (en) Treatment of cancer
ZA201005770B (en) The treatment of damaged skin
HUP1000688A2 (en) Use of trifluoro-phthalimides in the treatment of cancer
GB201020304D0 (en) Treatment and prevention of pain
AU2010904813A0 (en) Skin cancer prevention and treatment
AU2010900897A0 (en) Skin cancer prevention and treatment